N-[2-[1-(dimethylamino)ethylideneamino]ethyl]-2-methylprop-2-enamide
C10H19N3O — CID 102226187
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[1-(dimethylamino)ethylideneamino]ethyl]-2-methylprop-2-enamide
N-[2-[1-(dimethylamino)ethylideneamino]ethyl]-2-methylprop-2-enamide (PubChem CID 102226187) has the molecular formula C10H19N3O and a molecular weight of 197.28 g/mol. Its IUPAC name is N-[2-[1-(dimethylamino)ethylideneamino]ethyl]-2-methylprop-2-enamide.
Molecular Properties
| Compound Name | N-[2-[1-(dimethylamino)ethylideneamino]ethyl]-2-methylprop-2-enamide |
|---|---|
| PubChem CID | 102226187 |
| Molecular Formula | C10H19N3O |
| Molecular Weight | 197.28 g/mol |
| Exact Mass | 197.15 |
| IUPAC Name | N-[2-[1-(dimethylamino)ethylideneamino]ethyl]-2-methylprop-2-enamide |
| SMILES | C=C(C)C(=O)NCC/N=C(\C)N(C)C |
| InChI | InChI=1S/C10H19N3O/c1-8(2)10(14)12-7-6-11-9(3)13(4)5/h1,6-7H2,2-5H3,(H,12,14)/b11-9+ |
| InChIKey | HBOZAWHEJLQMGE-PKNBQFBNSA-N |
| XLogP | 0.66 |
| TPSA | 44.70 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 14 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 197.28 |
| LogP ≤ 5 | 0.66 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 102226187 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.